Mepolizumab has had a bumpy road to arriving at its indication in COPD. An FDA advisory committee in 2018 declined to ...

It would impose work requirements for low-income adults to receive Medicaid health insurance and increase them for food ...

While rates of bile duct injury were similar with robotic-assisted cholecystectomy and laparoscopic cholecystectomy among ...

With all of the healthcare funding cuts currently going on in Washington, there is one health service that has survived ...

And Arcutis Biotherapeutics announced approval of roflumilast (Zoryve) topical foam 0.3% for plaque psoriasis of the scalp ...

A newly proposed framework expands acute traumatic brain injury (TBI) assessment beyond the Glasgow Coma Scale (GCS).

Although the 400-person study was too small to really compare clinical outcomes, Tanigaki said a count of major adverse ...

The findings add to other research showing a lower risk of obesity-related cancers in patients taking GLP-1 drugs, a class of ...

Alpha-synuclein, TDP-43 signatures, and cerebral small vessel disease were common in people with discordant stages. Older ...

At the recent American Urological Association annual meeting, data on niraparib (Zejula) in treatment-naive, DNA damage repair (DDR)-deficient localized prostate cancer offered new insights -- but ...

An FDA advisory committee on Wednesday unanimously voted against recommending approval of the PARP inhibitor talazoparib ...